Karuna Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 334 | 0.000876% |
| State or Government | 15,770 | 0.0413% |
| Individual Insiders | 332,213 | 0.871% |
| Public Companies | 1,531,564 | 4.01% |
| General Public | 3,164,846 | 8.3% |
| Institutions | 33,102,925 | 86.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.5%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 4,671,216 | US$1.5b | -14.7% | 0.14% | |||
| 3,224,786 | US$1.1b | 0.66% | 0.02% | |||
| 2,865,994 | US$945.3m | 0% | 0.06% | |||
| 2,015,374 | US$664.7m | 2.67% | 0.01% | |||
| 1,531,564 | US$505.2m | 0% | no data | |||
| 1,381,149 | US$455.5m | 0% | 24.14% | |||
| 1,134,046 | US$374.0m | -11.8% | 0.06% | |||
| 1,066,200 | US$351.7m | 3,640% | 7.14% | |||
| 1,022,696 | US$337.3m | 0% | 58.66% | |||
| 986,710 | US$325.4m | 0% | 4.89% | |||
| 974,643 | US$321.5m | 4.92% | 0.01% | |||
| 569,722 | US$187.9m | 4.52% | 0.02% | |||
| 562,853 | US$185.6m | 250% | 0.03% | |||
| 515,024 | US$169.9m | 1.9% | 4.33% | |||
| 448,866 | US$148.0m | -89.6% | 0.01% | |||
| 377,155 | US$124.4m | 3.79% | 0.04% | |||
| 357,473 | US$117.9m | 1,470% | 1.22% | |||
| 333,144 | US$109.9m | 3.43% | 0.14% | |||
| 328,067 | US$108.2m | 5.32% | 0.01% | |||
| 315,892 | US$104.2m | 193% | 0.29% | |||
| 313,041 | US$103.2m | -5.04% | 0.03% | |||
| 287,037 | US$94.7m | -5.31% | 7.89% | |||
| 250,000 | US$82.5m | 0% | 4.24% | |||
| 237,656 | US$78.4m | 0.08% | 0.18% | |||
| 225,060 | US$74.2m | 3.08% | 0.01% |